BEGIN:VCALENDAR VERSION:2.0 PRODID:-//pretalx//sciencenext.org//EWPUU9 BEGIN:VTIMEZONE TZID:EET BEGIN:STANDARD DTSTART:20001029T030000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20061029T000000Z TZNAME:EET TZOFFSETFROM:+0300 TZOFFSETTO:+0200 END:STANDARD BEGIN:STANDARD DTSTART:20071028T050000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20141026T020000Z TZNAME:EET TZOFFSETFROM:+0300 TZOFFSETTO:+0200 END:STANDARD BEGIN:STANDARD DTSTART:20151108T050000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=11;UNTIL=20151108T020000Z TZNAME:EET TZOFFSETFROM:+0300 TZOFFSETTO:+0200 END:STANDARD BEGIN:STANDARD DTSTART:20160907T010000 RRULE:FREQ=YEARLY;BYDAY=1WE;BYMONTH=9 TZNAME:+03 TZOFFSETFROM:+0300 TZOFFSETTO:+0300 END:STANDARD BEGIN:DAYLIGHT DTSTART:20000326T020000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20060326T000000Z TZNAME:EEST TZOFFSETFROM:+0200 TZOFFSETTO:+0300 END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20070325T040000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20100328T020000Z TZNAME:EEST TZOFFSETFROM:+0200 TZOFFSETTO:+0300 END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20110328T040000 RRULE:FREQ=YEARLY;BYDAY=4MO;BYMONTH=3;UNTIL=20110328T020000Z TZNAME:EEST TZOFFSETFROM:+0200 TZOFFSETTO:+0300 END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20120325T040000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20130331T020000Z TZNAME:EEST TZOFFSETFROM:+0200 TZOFFSETTO:+0300 END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20140331T040000 RRULE:FREQ=YEARLY;BYDAY=5MO;BYMONTH=3;UNTIL=20140331T020000Z TZNAME:EEST TZOFFSETFROM:+0200 TZOFFSETTO:+0300 END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20150329T040000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20160327T020000Z TZNAME:EEST TZOFFSETFROM:+0200 TZOFFSETTO:+0300 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:pretalx-ifos2026-EWPUU9@sciencenext.org DTSTART;TZID=EET:20260909T151500 DTEND;TZID=EET:20260909T153000 DESCRIPTION:

This session presents a four-year experience from a specialized multidisciplinary clinic designed to manage Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). The model in tegrates Rhinology and immunology to offer comprehensive\, coordinated car e. Our session will highlight how this collaborative approach improved pat ient outcomes\, facilitated access to biologics\, and optimized treatment plans through shared decision-making.

Outcome Objectives: By the end of this session\, a ttendees will be able to:

  1. Explain the roles of various specialists in the multidisciplinary care of CRSwNP.

  2. Analyze the benefits and challenges of implementing a team-based clinical model.

    < /li>

  3. Recognize clinical indicat ors guiding the initiation of biologic therapy in CRSwNP.

  4. Demonstrate strategies for integrating multidisciplinary collaboration in their own practice settings.

    5. < /ol> DTSTAMP:20260813T221332Z LOCATION:Rhinology 6 (ICC - 3B/37) SUMMARY:Holistic Approach to CRSwNP patients: MDT Clinic Experience at a te rtiary Hospital - OMAR ABU SULIMAN URL:https://sciencenext.org/ifos2026/talk/EWPUU9/ END:VEVENT END:VCALENDAR